Great post @Quiltman
One of the things I find so atrractive about PAA is the potential of MPL to encompass its own entire class of drug. It is the same reason I keep banging on about the importance of PAA staying independent and only doing licensing and/or JV's rather than accepting a short-sighted T/O
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-850
-
- There are more pages in this discussion • 575 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |